These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6423929)

  • 21. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
    Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
    Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX; Li H
    Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density.
    Ozoran K; Paker N; Başgöze O; Hasçelik Z; Erzen C; Narman S; Ozker R
    J Int Med Res; 1989; 17(4):395-400. PubMed ID: 2792558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients.
    Atbinici H; Sipahioğlu S; Aksoy N; Baykara İ; Işıkan UE
    Acta Orthop Traumatol Turc; 2015; 49(2):160-5. PubMed ID: 26012937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of postmenopausal and senile osteoporosis with synthetic salmon calcitonin. A clinical study].
    Salvini S; Nicolazzo F; Farina P; Martelli G
    Clin Ter; 1987 Jun; 121(6):471-7. PubMed ID: 2973883
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term treatment with calcitonin in osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Horm Metab Res; 1993 Sep; 25(9):484-5. PubMed ID: 8225202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcitonin.
    Silverman SL
    Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of osteoporosis with calcitonin, with and without growth hormone.
    Aloia JF; Vaswani A; Kapoor A; Yeh JK; Cohn SH
    Metabolism; 1985 Feb; 34(2):124-9. PubMed ID: 3969014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin treatment of post-menopausal osteoporosis. Evaluation of efficacy by principal components analysis.
    Milhaud G; Talbot JN; Coutris G
    Biomedicine; 1975 May; 22(3):223-32. PubMed ID: 809068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long term treatment of osteoporosis with thyrocalcitonin. Apropos of 7 cases].
    Bloch-Michel H; Milhaud G; Coutris G; Waltzing P; Charret A; Morin Y; Verger D; Dussart N
    Rev Rhum Mal Osteoartic; 1970 Oct; 37(10):629-38. PubMed ID: 5482813
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of calcitonin or the anabolic steroid Decadurabolin on serum beta 2 microglobulin in osteoporotic postmenopausal women.
    Cantatore FP; Loperfido MC; Mancini L; Carrozzo M
    J Rheumatol; 1992 Nov; 19(11):1753-5. PubMed ID: 1491396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.
    Gallagher JC; Jerpbak CM; Jee WS; Johnson KA; DeLuca HF; Riggs BL
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3325-9. PubMed ID: 6954482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent acquisitions in therapy of osteoporosis of various etiologies with calcitonin].
    Vigo PL; Di Ciano L; Girardello R; Reschini E; Polli E
    Recenti Prog Med; 1977 Jun; 62(6):649-70. PubMed ID: 578332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.